4.7 C
New York
Saturday, February 24, 2024

Dr. Gottlieb says J&J Covid vaccine trial yields very good result and vaccine will aid U.S. pandemic response

  • Dr. Scott Gottlieb told CNBC that Johnson & Johnson's Covid vaccine provided "very good" clinical trial results.
  • "The immune protection that it affords seems to be pretty durable," he said Friday.
  • The former FDA chief and current Pfizer board member added that it is tough to compare J&J's results with other vaccine trials because they were conducted differently.

Related Articles

Latest Articles